Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Br J Oral Maxillofac Surg ; 59(7): 742-751, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34120778

RESUMO

A systematic review and network meta-analysis was conducted to compare different commercially available xenograft materials used in maxillary sinus floor elevation surgery (MSFES). Embase, PubMed, the Cochrane Library, Web of Science, Scopus, LILACS, and grey literature were searched up to 13 July 2020. Only randomised controlled trials (RCTs) were included. A frequentist network meta-analysis using a random effects model compared different commercially available xenograft materials. The primary outcomes were the percentage of newly-formed bone and residual bone-substitute rate. Both were measured by histomorphometric analysis from bone biopsies obtained during preparation of the implant site. Of the 659 studies initially identified, 11 involving 242 MSFES were included in the quantitative analyses. A total of six bone-substitute materials were analysed (Bio-Oss® (Geistlich Pharma), InduCera® Dual Coat, Lumina-Bone Porous® (Critéria), Osseous® (SIN - Sistema de Implantes Nacional), THE Graft® (Purgo Biologics), and Osteoplant Osteoxenon® (Bioteck)). The P-score estimation showed that Osteoplant Osteoxenon® produced the most newly-formed bone and reabsorbed faster than other xenograft materials after six months. The combination of Bio-Oss® plus bone marrow aspirate concentrate (BMAC) significantly increased the percentage of newly-formed bone compared with Bio-Oss® alone. In contrast, the addition of Emdogain® (Straumann) and leucocyte and platelet-rich fibrin (L-PRF) to Bio-Oss® did not significantly improve the amount of regenerated bone. Study-level data indicated that the percentage of newly-formed bone differs among commercially available xenograft materials. Osteoplant Osteoxenon® seems to result in the highest amount of new bone in MSFES.


Assuntos
Substitutos Ósseos , Levantamento do Assoalho do Seio Maxilar , Substitutos Ósseos/uso terapêutico , Transplante Ósseo , Implantação Dentária Endóssea , Xenoenxertos , Humanos , Seio Maxilar/cirurgia , Minerais/uso terapêutico , Metanálise em Rede
2.
Int J Oral Maxillofac Surg ; 49(6): 797-810, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31699633

RESUMO

In this systematic review and network meta-analysis including only randomized clinical trials (RCTs), different grafting materials used in alveolar ridge preservation after tooth extraction were analysed, focusing on histomorphometric new bone formation (NBF) in core biopsies obtained during implant placement. The PubMed, Embase, Cochrane Library, Web of Science, Scopus, and LILACS databases, as well as the grey literature, were searched for published and unpublished trials (from database inception to January 14, 2019). The primary outcome was the percentage of NBF. The secondary outcomes were the percentage of residual biomaterial and the percentage of soft tissue. An arm-based network meta-analysis was performed. The rank of intervention efficacy was obtained to measure the probability of each biomaterial being ranked first across all interventions. A total of 1526 studies were found, of which 38 were included for quantitative analysis. Three trials were rated as having a high risk of bias and 35 trials as having an unclear risk of bias. The network meta-analysis showed that nine grafting materials decreased NBF and 25 did not decrease NBF. The grafting material with the highest amount of NBF was plasma rich in growth factors. Due to the lack of studies with a low risk of bias, further RCTs are needed for definitive conclusions.


Assuntos
Aumento do Rebordo Alveolar , Materiais Biocompatíveis , Alvéolo Dental/cirurgia , Processo Alveolar , Transplante Ósseo , Extração Dentária
3.
Int J Oral Maxillofac Surg ; 48(3): 395-414, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30072300

RESUMO

The effect of platelet-rich fibrin (PRF) in enhancing the healing after oral surgical interventions is still a matter of debate. The purpose of this study was to identify instances where PRF has been shown to be effective in oral surgical procedures. A comprehensive literature search was performed up to 2017 on PubMed/MEDLINE, Cochrane Library, Web of Science, Scopus and LILACS databases and grey literature. The full-text of potentially relevant studies were reviewed and only randomized clinical trials (RCTs) were included. A total of 559 studies were found, of which 30 were included for qualitative analysis and 13 for quantitative analysis. Three review authors assessed the risk of bias independently. The available literature suggests that PRF has a positive effect in improving alveolar preservation on extraction sockets and around dental implants. The qualitative analysis showed a significantly better effect of PRF in promoting bone regeneration for alveolar cleft reconstruction. The meta-analysis for third molar surgery showed a decrease in prevalence of alveolar osteitis. PRF increased implant stability 1 week and 1 month after surgery (P=0.0005 and 0.0003). Due to the lack of studies with low risk of bias and a limited number of patients available, further RCTs are needed to confirm these results.


Assuntos
Procedimentos Cirúrgicos Bucais , Fibrina Rica em Plaquetas , Humanos
4.
Int J Oral Maxillofac Surg ; 46(9): 1138-1146, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28473242

RESUMO

The current literature was reviewed to analyze the effects of platelet-rich fibrin (PRF) on postoperative complications after mandibular third molar surgery (pain, alveolar osteitis, swelling, and bone healing). A comprehensive literature search was performed up to 2016 in the PubMed/MEDLINE, Cochrane Library, LILACS, and ScienceDirect databases and the grey literature. Additional records were identified through manual and reference searches. The full-text articles of potentially relevant studies were reviewed; only randomized clinical trials were included. Two review authors assessed the risk of bias independently. A total of 1430 publications were evaluated, of which seven were selected for qualitative analysis and two for quantitative analysis. A meta-analysis was performed only for alveolar osteitis, due to the considerable heterogeneity among studies for the other outcome variables. There were 485 extractions (243 test, 242 control) in 280 patients. PRF appeared to accelerate healing in mandibular third molar surgery, reducing postoperative pain and swelling. Quantitative analysis showed a decrease in prevalence of alveolar osteitis (odds ratio 0.31, 95% confidence interval 0.13-0.77, Z=2.54, P=0.01). Although more clinical trials of a better design and with larger samples are necessary to allow definitive conclusions to be drawn, PRF is a potentially useful biomaterial.


Assuntos
Mandíbula/cirurgia , Dente Serotino/cirurgia , Fibrina Rica em Plaquetas , Complicações Pós-Operatórias/prevenção & controle , Extração Dentária , Dente Impactado/cirurgia , Humanos , Cicatrização
5.
Int J Oral Maxillofac Surg ; 45(12): 1508-1512, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27688168

RESUMO

The objective of this study was to evaluate, through cone beam computed tomography, the immediate changes in pharyngeal airway space (PAS) after orthognathic surgery in class III patients, and to determine the influence of surgery on the development of obstructive sleep apnoea hypopnoea syndrome (OSAHS). A prospective study was conducted; 33 patients were divided into three groups: mandibular setback surgery (nine patients), bimaxillary surgery (18 patients), and maxillary advancement surgery (six patients). PAS measurements obtained pre- and postoperatively were compared using the t-test. All patients were assessed clinically for OSAHS before surgery and at 6 months postoperative using the Berlin questionnaire and a combined clinical assessment, which included the assessment of OSAHS symptoms, Epworth Sleepiness Scale score, and body mass index. Patients undergoing isolated mandibular setback surgery demonstrated a decrease in total PAS volume, in hypopharynx volume, and in minimum cross-sectional area of the pharynx immediately after surgery (P<0.05). The clinical analysis did not reveal signs or symptoms of OSAHS in any of the 33 patients. Although patients who underwent mandibular setback surgery alone demonstrated a volume reduction in the PAS and a decrease in minimum cross-sectional area, these reductions were not accompanied by signs or symptoms of OSAHS.


Assuntos
Má Oclusão Classe III de Angle/cirurgia , Procedimentos Cirúrgicos Ortognáticos/efeitos adversos , Faringe/diagnóstico por imagem , Complicações Pós-Operatórias/etiologia , Apneia Obstrutiva do Sono/etiologia , Adolescente , Adulto , Cefalometria , Tomografia Computadorizada de Feixe Cônico , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Osteotomia de Le Fort , Estudos Prospectivos , Adulto Jovem
6.
Rev. bras. odontol ; 52(5): 22-6, set.-out. 1995. ilus
Artigo em Português | LILACS, BBO - Odontologia | ID: lil-160047

RESUMO

É apresentado um caso de granuloma de células gigantes central (GCGC) em osso maxilar, de um paciente com 64 anos de idade, no qual se optou pela enucleaçäo da lesäo através do acesso de Weber-Ferguson-Longmire. Com base na literatura revisada, discutem-se a etiologia, os aspectos clínicos, radiográficos, histológicos, e o tratamento desta condiçäo. O GCGC é diferenciado das demais lesöes de células gigantes baseando-se na sua apresentaçäo clínica, nas características histológicas e radiográficas e nos exames laboratoriais. O seu curso clínico é benigno, respondendo bem, na maioria dos casos, ao tratamento cirúrgico conservador


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Granuloma de Células Gigantes/diagnóstico , Granuloma de Células Gigantes/etiologia , Granuloma de Células Gigantes/terapia , Maxila/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...